Dr. Michael Sidler serves as Co-Founding Partner at Redalpine Venture Partners. He also is an Angel Investor. He serves as Board Member at Aktiia and Lunaphore Technologies. He serves as Chairman at BiognoSYS. He also serves as Board Member at Versantis. He also serves as Vice Chairman at Startup Invest. He served as the Board Member at and Genialis, OnSite Lab, Redbiotec and Memo Therapeutics. He also served as a Board Observer at TOLREMO therapeutics. He has earned a Ph.D. in Life Sciences. Before Redalpine, Michael was responsible for corporate investments and M&A at Prionics AG, a Biotech company in Schlieren, Switzerland, where under his guidance several acquisitions have been completed. From 1998 to 2003, Michael was with The Boston Consulting Group in Zürich and Toronto as a Consultant and Project Leader in several different industries and roles. Michael Sidler has a Ph.D. in Life Sciences from the University of Zürich. He is a member of several organizations, juries, and boards for the support of innovation and startups (Venturekick, Technopark Zürich, Swiss Startup Finance, Kickstart Accelerator) and a coach for the Swiss governmental program CTI-Startup. He served as Board Membe at Versantis and Kenbi.